DIALYSIS · CCN 392538

DaVita Philadelphia PMC Dialysis

Philadelphia, PA 19104

DialysisProfitDaVita
$6.7M
TOTAL REVENUE
16.2%
OPERATING MARGIN
5 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$6.7M
Total costs
$5.6M
Operating income (rev − costs)
$1.1M
Operating margin
16.2%
Total charges
$6.8M
Total treatments
16,621
Dialysis stations
27

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.7152—
Fistula Rate
DFC_FISTULA_RATE
66.7139—
Five Star Rating
DFC_FIVE_STAR
5——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
3.838—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
142.5104—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.26——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
9139—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
14415—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
24.3120—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
25.782—
Standardized ED Visits Ratio
DFC_SEDR
0.9231—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
20.930—